Adenosine and the AV Node
The hard reboot. A drug that transiently paralyzes the AV node in seconds, then vanishes without a trace.
Sometimes, you need to turn the heart off and turn it back on again.
The previous chapters have described drugs that gently reshape the electrical landscape over hours and days: slowing sodium channels, blunting sympathetic tone, stretching the refractory period, dampening calcium currents. Adenosine operates on an entirely different timescale. It is a biological sledgehammer with a half-life measured in seconds.
When you push adenosine into a vein, it reaches the heart in a single circulatory pass and, for a brief window, completely shuts down the AV node. Every beat that depends on the node to survive is instantly destroyed. Every beat that doesn't depend on the node is unmasked. Then the drug disappears, and the heart wakes up.
The Potassium Flood
Adenosine binds to A1 receptors on the surface of AV nodal cells. These receptors are coupled to a specific type of G-protein (Gi) that does two things simultaneously.
First, it inhibits adenylyl cyclase, dropping intracellular cAMP levels. This weakens the calcium currents that the AV node depends on for depolarization (the same pathway that beta-blockers target, but far more aggressively).
Second, and more dramatically, it activates a dedicated potassium channel called IK,Ado. This channel opens wide and dumps positive potassium ions out of the cell. The resting membrane potential plunges to an extremely negative value, far below the threshold that any calcium channel could overcome.
The AV node becomes, for a few seconds, electrically inert. No impulse from the atria can cross to the ventricles.
Adenosine forces open a powerful potassium channel. K+ floods out of the cell, driving the membrane potential to roughly −80 to −90 mV. At that voltage, the L-type calcium channels that drive nodal depolarization cannot activate. The node is silenced.
By inhibiting adenylyl cyclase, adenosine slashes the cAMP that normally keeps L-type calcium channels primed. Even if the membrane weren't hyperpolarized, the calcium channels are disarmed. It's a two-pronged assault on the node.
The Diagnostic Fork
When a patient arrives with a narrow-complex tachycardia at 170 bpm, the immediate question is: does this arrhythmia need the AV node to survive? Adenosine answers the question in real time, on the monitor, in front of you.
The circuit uses the AV node as one of its limbs. The moment the node is paralyzed, the loop cannot complete. The tachycardia terminates abruptly. The monitor shows a brief pause, then normal sinus rhythm walks back in.
The arrhythmia lives entirely in the atria. It doesn't care about the AV node. When adenosine paralyzes the node, the atrial rhythm continues undisturbed. But the ventricular rate drops to zero for a few seconds. Suddenly, previously hidden flutter waves or P waves emerge clearly on the rhythm strip, marching independently at 300 bpm.
Gone in Seconds
Adenosine has a plasma half-life of roughly 6 to 10 seconds. Red blood cells and endothelial cells break it down almost instantly through adenosine deaminase and cellular uptake. By the time the patient feels the transient chest tightness and flushing (which nearly everyone experiences), the drug is already disappearing.
This ultrashort duration is what makes adenosine safe enough to use as a diagnostic tool. If you push it and nothing happens, you've learned something about the rhythm. If it terminates the tachycardia, you've learned something else. If it unmasks flutter, you've made a diagnosis. In every scenario, the drug is gone within 30 seconds.
The rapid metabolism also explains the administration technique. Adenosine must be given as a fast IV push through a large, proximal vein (antecubital or higher), followed immediately by a saline flush. If you push it slowly or through a distal hand IV, it breaks down in transit and never reaches the heart in sufficient concentration.
When the Reboot Fails
Adenosine has one more use that ties directly back to Volume V. Some ventricular tachycardias are driven by cAMP-mediated triggered activity, particularly the idiopathic outflow tract VTs. Because adenosine crushes cAMP levels (via the Gi pathway), it can terminate these rhythms. A VT that stops with adenosine is strong evidence for a triggered, cAMP-dependent mechanism rather than reentry.
Conversely, adenosine has no effect on scar-based reentrant VT (the circuit doesn't depend on calcium channels or cAMP). And it has no effect on atrial fibrillation, because the chaotic wavelets don't require the AV node to exist. In AFib, adenosine may transiently slow the ventricular response by blocking the node, but the fibrillation continues unabated in the atria.
Caffeine and theophylline are competitive antagonists at the A1 receptor. They physically sit in the binding pocket and block adenosine from reaching it.
A patient who arrives in the emergency department with AVNRT after consuming several cups of coffee presents a practical challenge. At standard doses (6 mg, then 12 mg), the adenosine molecules are outnumbered by caffeine molecules already occupying the receptors. The drug simply bounces off, and the tachycardia continues.
The solution is to push higher doses (up to 18-24 mg in some cases) to outcompete the caffeine through sheer concentration. Alternatively, dipyridamole (which blocks adenosine breakdown, keeping levels high for longer) can potentiate the effect. On the other side, patients taking dipyridamole or carbamazepine may be exquisitely sensitive to adenosine, requiring much lower starting doses.
Key Takeaways
- Adenosine activates IK,Ado, flooding potassium out of AV nodal cells and hyperpolarizing them to an un-excitable state. It also suppresses cAMP, disarming the calcium channels. The node is transiently paralyzed.
- If the tachycardia terminates, it required the AV node (AVNRT, AVRT). If the tachycardia persists but flutter waves or P waves are unmasked, the rhythm is atrial in origin (Flutter, Atrial Tachycardia).
- The half-life is 6-10 seconds. Red blood cells metabolize it almost instantly. This makes it safe as a diagnostic tool, but it must be pushed fast through a proximal IV to arrive at the heart intact.
- Adenosine terminates some VTs (outflow tract, cAMP-dependent triggered activity) but has no effect on scar-based reentrant VT. A VT that stops with adenosine points strongly toward a triggered mechanism.
- Caffeine and theophylline are competitive antagonists at the A1 receptor. Patients on caffeine may need higher doses; patients on dipyridamole may need much lower doses.